Skip to main content
Top
Published in: Infection 2/2023

Open Access 03-11-2022 | Leishmania | Case Report

Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review

Authors: Marco Busutti, Alessandro Deni, Alessandra Mistral De Pascali, Margherita Ortalli, Luciano Attard, Bianca Granozzi, Benedetta Fabbrizio, Gaetano La Manna, Giorgia Comai, Stefania Varani

Published in: Infection | Issue 2/2023

Login to get access

Abstract

Purpose

Visceral leishmaniasis (VL) has become a rising concern to transplantation teams, being associated with graft dysfunction and reduced survival of renal transplant recipients. Here, we describe a case of VL occurring in a kidney transplant (KT) recipient in Italy, a country in which Leishmania infantum is endemic and we reviewed the literature on the clinical course and diagnosis of VL in KT recipients residing or travelling to southern Europe.

Results

The VL case was diagnosed 18 months after transplant and 28 days after the onset of symptoms by quantitative PCR (qPCR) on peripheral blood. A graft biopsy showed renal involvement, and PCR performed on graft tissue displayed the presence of Leishmania DNA. The retrospective confirmation of Leishmania-positive serology in a serum sample collected before transplantation, as well as the absence of anti-Leishmania IgG in the graft donor strongly suggest that reactivation of a latent parasitic infection caused VL in the current case.

Conclusion

VL is often underdiagnosed in transplant recipients, despite the presence of latent Leishmania infection being reported in endemic countries. This case report, as well as the literature review on leishmaniasis in KT recipients, underline the importance of rapid VL diagnosis to promptly undergo treatment. Serology is scarcely sensitive in immunocompromised patients, thus molecular tests in peripheral blood should be implemented and standardized for both VL identification and follow-up.
Literature
1.
go back to reference Gradoni L, López-Vélez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European Region. Geneva: World Health Organization; 2017. Gradoni L, López-Vélez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European Region. Geneva: World Health Organization; 2017.
2.
go back to reference Clemente WT, Mourão PHO, Lopez-Medrano F, Schwartz BS, García-Donoso C, Torre-Cisneros J. Visceral and cutaneous leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S8–15.PubMedCrossRef Clemente WT, Mourão PHO, Lopez-Medrano F, Schwartz BS, García-Donoso C, Torre-Cisneros J. Visceral and cutaneous leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S8–15.PubMedCrossRef
3.
go back to reference Gajurel K, Dhakal R, Deresinski S. Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients. Clin Transpl. 2017;31:e12867.CrossRef Gajurel K, Dhakal R, Deresinski S. Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients. Clin Transpl. 2017;31:e12867.CrossRef
4.
go back to reference La Hoz RM, Morris MI, Transplantation IDCOPOTASO. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients. Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:13546. La Hoz RM, Morris MI, Transplantation IDCOPOTASO. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients. Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:13546.
5.
go back to reference Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN. Renal involvement in leishmaniasis: a review of the literature. NDT Plus. 2011;4:147–52.PubMedPubMedCentral Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN. Renal involvement in leishmaniasis: a review of the literature. NDT Plus. 2011;4:147–52.PubMedPubMedCentral
6.
go back to reference Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8:191–9.PubMedCrossRef Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8:191–9.PubMedCrossRef
7.
go back to reference Varani S, Ortalli M, Attard L, et al. Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy. PLoS ONE. 2017;12: e0183699.PubMedPubMedCentralCrossRef Varani S, Ortalli M, Attard L, et al. Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy. PLoS ONE. 2017;12: e0183699.PubMedPubMedCentralCrossRef
8.
go back to reference Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42:5249–55.PubMedPubMedCentralCrossRef Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol. 2004;42:5249–55.PubMedPubMedCentralCrossRef
9.
go back to reference Ortalli M, De Pascali AM, Longo S, et al. Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy. J Infect. 2020;80:116–20.PubMedCrossRef Ortalli M, De Pascali AM, Longo S, et al. Asymptomatic Leishmania infantum infection in blood donors living in an endemic area, northeastern Italy. J Infect. 2020;80:116–20.PubMedCrossRef
10.
go back to reference Lévêque MF, Battery E, Delaunay P, et al. Evaluation of six commercial kits for the serological diagnosis of Mediterranean visceral leishmaniasis. PLoS Negl Trop Dis. 2020;14: e0008139.PubMedPubMedCentralCrossRef Lévêque MF, Battery E, Delaunay P, et al. Evaluation of six commercial kits for the serological diagnosis of Mediterranean visceral leishmaniasis. PLoS Negl Trop Dis. 2020;14: e0008139.PubMedPubMedCentralCrossRef
11.
go back to reference Akuffo H, Costa C, van Griensven J, Burza S, Moreno J, Herrero M. New insights into leishmaniasis in the immunosuppressed. PLoS Negl Trop Dis. 2018;12: e0006375.PubMedPubMedCentralCrossRef Akuffo H, Costa C, van Griensven J, Burza S, Moreno J, Herrero M. New insights into leishmaniasis in the immunosuppressed. PLoS Negl Trop Dis. 2018;12: e0006375.PubMedPubMedCentralCrossRef
12.
go back to reference Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. J Infect. 1990;21:107–10.PubMedCrossRef Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient. J Infect. 1990;21:107–10.PubMedCrossRef
13.
go back to reference Le Cacheux P, Hurault de Ligny B, Reman O, Ryckelynck JP. Visceral leishmaniasis of favourable course in a patient with renal transplantation. Rev Med Interne. 1990;11:250–1.PubMed Le Cacheux P, Hurault de Ligny B, Reman O, Ryckelynck JP. Visceral leishmaniasis of favourable course in a patient with renal transplantation. Rev Med Interne. 1990;11:250–1.PubMed
14.
go back to reference Rousaud F, Solá R, Oliver A, Ayats R, del Rio G. Primary visceral leishmaniasis in a renal transplant patient. Nefrologia. 1991;11:72–4. Rousaud F, Solá R, Oliver A, Ayats R, del Rio G. Primary visceral leishmaniasis in a renal transplant patient. Nefrologia. 1991;11:72–4.
15.
go back to reference Orofino L, Marcen R, Gamez C, et al. Visceral leishmaniasis in renal transplant patients. Nephrol Dial Transpl. 1992;7:651.CrossRef Orofino L, Marcen R, Gamez C, et al. Visceral leishmaniasis in renal transplant patients. Nephrol Dial Transpl. 1992;7:651.CrossRef
16.
go back to reference Moulin B, Ollier J, Bouchouareb D, Purgus R, Olmer M. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient. Nephron. 1992;60:360–2.PubMedCrossRef Moulin B, Ollier J, Bouchouareb D, Purgus R, Olmer M. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient. Nephron. 1992;60:360–2.PubMedCrossRef
17.
go back to reference Jokipii L, Salmela K, Saha H, et al. Leishmaniasis diagnosed from bronchoalveolar lavage. Scand J Infect Dis. 1992;24:677–81.PubMedCrossRef Jokipii L, Salmela K, Saha H, et al. Leishmaniasis diagnosed from bronchoalveolar lavage. Scand J Infect Dis. 1992;24:677–81.PubMedCrossRef
18.
go back to reference Dunan S, Mary C, Gambarelli F, et al. Four cases of visceral leishmaniasis in renal graft recipients. Epidemiological and therapeutical reflexions. Med Mal Infect. 1993;23:297–301.CrossRef Dunan S, Mary C, Gambarelli F, et al. Four cases of visceral leishmaniasis in renal graft recipients. Epidemiological and therapeutical reflexions. Med Mal Infect. 1993;23:297–301.CrossRef
19.
go back to reference Torregrosa JV, Ricart MJ, Montesinos M, et al. Visceral leishmaniasis-like cause of unexplained fever in a reno-pancreatic graft recipient. Nephron. 1993;65:318–9.PubMedCrossRef Torregrosa JV, Ricart MJ, Montesinos M, et al. Visceral leishmaniasis-like cause of unexplained fever in a reno-pancreatic graft recipient. Nephron. 1993;65:318–9.PubMedCrossRef
20.
go back to reference Moroni G, Bossi L. Don’t forget visceral leishmaniasis in transplant patients. Nephrol Dial Transpl. 1995;10:563–4.CrossRef Moroni G, Bossi L. Don’t forget visceral leishmaniasis in transplant patients. Nephrol Dial Transpl. 1995;10:563–4.CrossRef
21.
go back to reference Esteban RJ, Bravo JA, Osuna A, Asensio C. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure. Nephrol Dial Transpl. 1996;11:1898.CrossRef Esteban RJ, Bravo JA, Osuna A, Asensio C. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure. Nephrol Dial Transpl. 1996;11:1898.CrossRef
22.
go back to reference Torrús D, Boix V, Massa B, Portilla J, Pérez-Mateo M. Fluconazole plus allopurinol in treatment of visceral leishmaniasis. J Antimicrob Chemother. 1996;37:1042–3.PubMedCrossRef Torrús D, Boix V, Massa B, Portilla J, Pérez-Mateo M. Fluconazole plus allopurinol in treatment of visceral leishmaniasis. J Antimicrob Chemother. 1996;37:1042–3.PubMedCrossRef
23.
go back to reference Apaydin S, Ataman R, Serdengeçt K, et al. Visceral leishmaniasis without fever in a kidney transplant recipient. Nephron. 1997;75:241–2.PubMedCrossRef Apaydin S, Ataman R, Serdengeçt K, et al. Visceral leishmaniasis without fever in a kidney transplant recipient. Nephron. 1997;75:241–2.PubMedCrossRef
24.
go back to reference Berenguer J, Gómez-Campderá F, Padilla B, et al. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review. Transplantation. 1998;65:1401–4.PubMedCrossRef Berenguer J, Gómez-Campderá F, Padilla B, et al. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review. Transplantation. 1998;65:1401–4.PubMedCrossRef
25.
go back to reference Gómez Campderá F, Berenguer J, Anaya F, Rodriguez M, Valderrábano F. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative. Am J Nephrol. 1998;18:171.PubMedCrossRef Gómez Campderá F, Berenguer J, Anaya F, Rodriguez M, Valderrábano F. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative. Am J Nephrol. 1998;18:171.PubMedCrossRef
26.
go back to reference Boletis JN, Pefanis A, Stathakis C, Helioti H, Kostakis A, Giamarellou H. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome). Clin Infect Dis. 1999;28:1308–9.PubMedCrossRef Boletis JN, Pefanis A, Stathakis C, Helioti H, Kostakis A, Giamarellou H. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome). Clin Infect Dis. 1999;28:1308–9.PubMedCrossRef
27.
go back to reference Hernández-Pérez J, Yebra-Bango M, Jiménez-Martínez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis. 1999;29:918–21.PubMedCrossRef Hernández-Pérez J, Yebra-Bango M, Jiménez-Martínez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis. 1999;29:918–21.PubMedCrossRef
28.
go back to reference Hueso M, Bover J, Serón D, et al. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate—cure with ketoconazole and allopurinol. Nephrol Dial Transpl. 1999;14:2941–3.CrossRef Hueso M, Bover J, Serón D, et al. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate—cure with ketoconazole and allopurinol. Nephrol Dial Transpl. 1999;14:2941–3.CrossRef
29.
go back to reference Llorente S, Gimeno L, Navarro MJ, Moreno S, Rodriguez-Gironés M. Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation. 2000;70:800–1.PubMedCrossRef Llorente S, Gimeno L, Navarro MJ, Moreno S, Rodriguez-Gironés M. Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials. Transplantation. 2000;70:800–1.PubMedCrossRef
30.
go back to reference Rodríguez-Wilhelmi P, Panizo C, Ruza E, Rocha E. Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients. Med Clin (Barc). 2001;116:37–8.PubMedCrossRef Rodríguez-Wilhelmi P, Panizo C, Ruza E, Rocha E. Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients. Med Clin (Barc). 2001;116:37–8.PubMedCrossRef
31.
go back to reference Sabbatini M, Pisani A, Ragosta A, Gallo R, Borrelli F, Cianciaruso B. Visceral Leishmaniasis in renal transplant recipients: is it still a challenge to the nephrologist? Transplantation. 2002;73:299–301.PubMedCrossRef Sabbatini M, Pisani A, Ragosta A, Gallo R, Borrelli F, Cianciaruso B. Visceral Leishmaniasis in renal transplant recipients: is it still a challenge to the nephrologist? Transplantation. 2002;73:299–301.PubMedCrossRef
32.
go back to reference Sipsas NV, Boletis J. Fever, hepatosplenomegaly, and pancytopenia in a renal transplant recipient. Transpl Infect Dis. 2003;5:47–52.PubMedCrossRef Sipsas NV, Boletis J. Fever, hepatosplenomegaly, and pancytopenia in a renal transplant recipient. Transpl Infect Dis. 2003;5:47–52.PubMedCrossRef
33.
go back to reference Basset D, Faraut F, Marty P, et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect. 2005;7:1370–5.PubMedCrossRef Basset D, Faraut F, Marty P, et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect. 2005;7:1370–5.PubMedCrossRef
34.
go back to reference Veroux M, Corona D, Giuffrida G, et al. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management. Transpl Infect Dis. 2010;12:387–91.PubMedCrossRef Veroux M, Corona D, Giuffrida G, et al. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management. Transpl Infect Dis. 2010;12:387–91.PubMedCrossRef
35.
go back to reference Dettwiler S, McKee T, Hadaya K, Chappuis F, van Delden C, Moll S. Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction. Am J Transpl. 2010;10:1486–9.CrossRef Dettwiler S, McKee T, Hadaya K, Chappuis F, van Delden C, Moll S. Visceral leishmaniasis in a kidney transplant recipient: parasitic interstitial nephritis, a cause of renal dysfunction. Am J Transpl. 2010;10:1486–9.CrossRef
36.
go back to reference Simon I, Wissing KM, Del Marmol V, et al. Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature. Transpl Infect Dis. 2011;13:397–406.PubMedCrossRef Simon I, Wissing KM, Del Marmol V, et al. Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature. Transpl Infect Dis. 2011;13:397–406.PubMedCrossRef
37.
go back to reference Postorino MC, Bellantoni M, Catalano C, et al. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case. J Nephrol. 2011;24:530–4.PubMedCrossRef Postorino MC, Bellantoni M, Catalano C, et al. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case. J Nephrol. 2011;24:530–4.PubMedCrossRef
38.
go back to reference Yücel S, Ozcan D, Seçkin D, Allahverdiyev AM, Kayaselçuk F, Haberal M. Visceral leishmaniasis with cutaneous dissemination in a renal transplant recipient. Eur J Dermatol. 2013;23:892–3.PubMedCrossRef Yücel S, Ozcan D, Seçkin D, Allahverdiyev AM, Kayaselçuk F, Haberal M. Visceral leishmaniasis with cutaneous dissemination in a renal transplant recipient. Eur J Dermatol. 2013;23:892–3.PubMedCrossRef
39.
go back to reference Duvignaud A, Receveur MC, Ezzedine K, Pistone T, Malvy D. Visceral leishmaniasis due to Leishmania infantum in a kidney transplant recipient living in France. Travel Med Infect Dis. 2015;13:115–6.PubMedCrossRef Duvignaud A, Receveur MC, Ezzedine K, Pistone T, Malvy D. Visceral leishmaniasis due to Leishmania infantum in a kidney transplant recipient living in France. Travel Med Infect Dis. 2015;13:115–6.PubMedCrossRef
40.
go back to reference Pedroso JA, Paola Salerno M, Spagnoletti G, et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. Transpl Proc. 2014;46:2365–7.CrossRef Pedroso JA, Paola Salerno M, Spagnoletti G, et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. Transpl Proc. 2014;46:2365–7.CrossRef
41.
go back to reference Pérez-Jacoiste Asín MA, Carrasco-Antón N, Fernández-Ruiz M, et al. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: a case series from Spain. Transpl Infect Dis. 2017;19:13546.CrossRef Pérez-Jacoiste Asín MA, Carrasco-Antón N, Fernández-Ruiz M, et al. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: a case series from Spain. Transpl Infect Dis. 2017;19:13546.CrossRef
42.
go back to reference Clavijo Sánchez F, Vázquez Sánchez T, Cabello Díaz M, Sola Moyano VE, Jironada Gallego C, Hernández MD. Visceral leishmaniasis in renal transplant recipients: report of 2 cases. Transpl Proc. 2018;50:581–2.CrossRef Clavijo Sánchez F, Vázquez Sánchez T, Cabello Díaz M, Sola Moyano VE, Jironada Gallego C, Hernández MD. Visceral leishmaniasis in renal transplant recipients: report of 2 cases. Transpl Proc. 2018;50:581–2.CrossRef
44.
go back to reference Comai G, Mistral De Pascali A, Busutti M, et al. Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates. J Nephrol. 2021;34:191–5.PubMedCrossRef Comai G, Mistral De Pascali A, Busutti M, et al. Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates. J Nephrol. 2021;34:191–5.PubMedCrossRef
45.
go back to reference Clemente W, Vidal E, Girão E, et al. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study. Clin Microbiol Infect. 2015;21:89–95.PubMedCrossRef Clemente W, Vidal E, Girão E, et al. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study. Clin Microbiol Infect. 2015;21:89–95.PubMedCrossRef
46.
go back to reference van Griensven J, Diro E. Visceral leishmaniasis: recent advances in diagnostics and treatment regimens. Infect Dis Clin N Am. 2019;33:79–99.CrossRef van Griensven J, Diro E. Visceral leishmaniasis: recent advances in diagnostics and treatment regimens. Infect Dis Clin N Am. 2019;33:79–99.CrossRef
47.
go back to reference de Ruiter CM, van der Veer C, Leeflang MM, Deborggraeve S, Lucas C, Adams ER. Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy. J Clin Microbiol. 2014;52:3147–55.PubMedPubMedCentralCrossRef de Ruiter CM, van der Veer C, Leeflang MM, Deborggraeve S, Lucas C, Adams ER. Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy. J Clin Microbiol. 2014;52:3147–55.PubMedPubMedCentralCrossRef
48.
go back to reference van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20:286–99.PubMedCrossRef van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20:286–99.PubMedCrossRef
49.
go back to reference Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63:e202–64. https://doi.org/10.1093/cid/ciw670.CrossRefPubMed Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016;63:e202–64. https://​doi.​org/​10.​1093/​cid/​ciw670.CrossRefPubMed
51.
go back to reference Oliveira MJ, Silva Júnior GB, Abreu KL, et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am J Trop Med Hyg. 2010;82:449–53.PubMedPubMedCentralCrossRef Oliveira MJ, Silva Júnior GB, Abreu KL, et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am J Trop Med Hyg. 2010;82:449–53.PubMedPubMedCentralCrossRef
52.
go back to reference Dutra M, Martinelli R, de Carvalho EM, Rodrigues LE, Brito E, Rocha H. Renal involvement in visceral leishmaniasis. Am J Kidney Dis. 1985;6:22–7.PubMedCrossRef Dutra M, Martinelli R, de Carvalho EM, Rodrigues LE, Brito E, Rocha H. Renal involvement in visceral leishmaniasis. Am J Kidney Dis. 1985;6:22–7.PubMedCrossRef
53.
55.
go back to reference Sethi S, Fervenza FC, Siddiqui A, Quint PS, Pritt BS. Leishmaniasis-associated membranoproliferative glomerulonephritis with massive complement deposition. Kidney Int Rep. 2016;1:125–30.PubMedPubMedCentralCrossRef Sethi S, Fervenza FC, Siddiqui A, Quint PS, Pritt BS. Leishmaniasis-associated membranoproliferative glomerulonephritis with massive complement deposition. Kidney Int Rep. 2016;1:125–30.PubMedPubMedCentralCrossRef
Metadata
Title
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review
Authors
Marco Busutti
Alessandro Deni
Alessandra Mistral De Pascali
Margherita Ortalli
Luciano Attard
Bianca Granozzi
Benedetta Fabbrizio
Gaetano La Manna
Giorgia Comai
Stefania Varani
Publication date
03-11-2022
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 2/2023
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01943-3

Other articles of this Issue 2/2023

Infection 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.